创尔生物 (831187.OC)

+ 收藏

利润表(创尔生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2022年年报2022年三季报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 211,855,998.98139,559,639.22242,055,714.84170,209,342.38106,653,356.14
 营业收入(元) 211,855,998.98139,559,639.22242,055,714.84170,209,342.38106,653,356.14
二、营业总成本(元) 174,841,521.88115,177,712.98205,131,695.96146,420,516.4490,108,115.13
 营业成本(元) 45,407,657.2029,757,855.9754,140,906.8236,692,573.6822,218,004.41
 研发费用(元) 11,429,423.067,513,982.4918,240,769.3414,106,565.619,705,364.13
 营业税金及附加(元) 2,036,229.951,293,712.491,242,448.24742,052.57510,052.67
 销售费用(元) 96,166,013.4664,137,310.58111,047,923.2379,488,564.1047,052,269.41
 管理费用(元) 19,725,718.8512,462,033.7120,423,751.4915,409,310.4210,617,140.09
 财务费用(元) 76,479.3612,817.7435,896.84-18,549.945,284.42
  其中:利息费用(元) 365,392.39257,741.38699,449.69546,662.14377,779.10
  其中:利息收入(元) 652,385.27501,664.591,158,129.86879,322.83586,360.50
三、其他经营收益
 加:公允价值变动收益(元) 1,245,199.79905,080.21374,807.07675,930.50406,654.95
 加:投资收益(元) -335,860.38-279,810.60499,441.40533,418.27392,240.00
 资产处置收益(元) 2,775.002,775.00-28.75-28.75-28.75
 资产减值损失(元) -1,280,102.35-1,330,577.29-274,270.21-198,330.74-289,826.38
 信用减值损失(元) -224,663.22-198,407.29193,935.6061,627.0138,662.44
 其他收益(元) 537,590.44370,867.023,458,149.332,809,651.501,492,830.22
四、营业利润(元) 36,959,416.3823,851,853.2941,176,053.3227,671,093.7318,585,773.49
 加:营业外收入(元) 2,227,567.731,269,069.191,458,149.591,084,173.76670,547.72
 减:营业外支出(元) 30,037.245,385.24419,209.07157,256.7572,881.10
五、利润总额(元) 39,156,946.8725,115,537.2442,214,993.8428,598,010.7419,183,440.11
 减:所得税费用(元) 5,648,529.803,575,697.007,068,117.377,534,124.685,169,176.62
六、净利润(元) 33,508,417.0721,539,840.2435,146,876.4721,063,886.0614,014,263.49
(一)按经营持续性分类
  持续经营净利润(元) 33,508,417.0721,539,840.2435,146,876.4721,063,886.0614,014,263.49
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 33,481,938.7921,497,184.0535,199,205.4521,124,345.7414,075,973.83
  少数股东损益(元) 26,478.2842,656.19-52,328.98-60,459.68-61,710.34
 扣除非经常性损益后的净利润(元) 30,243,872.7819,418,994.2330,220,831.77-11,644,515.82
七、每股收益
 一、基本每股收益(元) 0.390.250.410.250.17
 二、稀释每股收益(元) 0.390.250.410.250.17
九、综合收益总额(元) 33,508,417.0721,539,840.2435,146,876.4721,063,886.0614,014,263.49
 归属于母公司所有者的综合收益总额(元) 33,481,938.7921,497,184.0535,199,205.4521,124,345.7414,075,973.83
 归属于少数股东的综合收益总额(元) 26,478.2842,656.19-52,328.98-60,459.68-61,710.34
公告日期 2023-11-202023-08-302023-04-252023-11-202022-08-29
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院